PT  - JOURNAL ARTICLE
AU  - Masahiro Sonoo
AU  - Takamichi Kanbayashi
AU  - Takayoshi Shimohata
AU  - Masahito Kobayashi
AU  - Masashi Idogawa
AU  - Hideyuki Hayashi
TI  - Estimation of the true infection rate and infection fatality rate of coronavirus disease 2019 in each country
AID  - 10.1101/2020.05.13.20101071
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.13.20101071
4099  - http://medrxiv.org/content/early/2020/06/27/2020.05.13.20101071.short
4100  - http://medrxiv.org/content/early/2020/06/27/2020.05.13.20101071.full
AB  - The True Infection Rate (TIR) in the whole population of each country and the Infection Fatality Rate (IFR) for coronavirus disease 2019 (COVID-19) are unknown. We devised a simple method to infer TIR and IFR based on the open data. The estimated TIR was compared with local antibody surveys. Estimated IFR took on a wide range of values up to 10%. The importance of the attenuation of the viral virulence is emphasized.Coronavirus disease 2019 (COVID-19) pandemic is a worldwide peril. The True Infection Rate (TIR) of COVID-19 in the whole population of each country and the Infection Fatality Rate (IFR) would be important parameters for guiding the strategy of public health, although they are unknown yet. We devised a simple method to infer TIR and IFR based on the open data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding reportedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of the Teikyo University judged that no approval is necessary for this study utilizing only open data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesProf. Masahiro Sonoo, the corresponding author has the availability of all data referred to in the manuscript.